Anand V Kulkarni
@anandvkulkarni.bsky.social
460 followers 320 following 17 posts
Hepatologist at AIG Hospitals, Hyderabad, India. Interests in ALD, ACLF & HCC
Posts Media Videos Starter Packs
anandvkulkarni.bsky.social
Thank you Hanna. In our settings most patients don’t agree for LT at all & we see at least 4 new AH patients per day and hardly one may fit for steroids therapy up front. We usually stabilize and then start steroids. Under supervision they do pretty well.
anandvkulkarni.bsky.social
Tips cannot prevent cirrhosis progression. Patients are okay without bleed for 3-4 years- then continue to develop complications. Having said that yes,I strongly recommend TIPS for bleeders but not for refractory ascites.Very poor outcomes! The QoL post TIPS for ascites is significantly affected.
Reposted by Anand V Kulkarni
liveloveliver.bsky.social
📢Thrilled to share our latest review article. Greatful to Prof. Rakhi Maiwall. We explore challenges of managing septic shock in cirrhosis and advocate for personalized approaches
pubmed.ncbi.nlm.nih.gov/39744868/

#liversky #Medsky #GIsky

@anandvkulkarni.bsky.social
Reposted by Anand V Kulkarni
ebtapper.bsky.social
There are *some* people whom steroids help

There is still value in trials, pragmatic trials, that refine inclusion criteria, dose, duration, and stopping rules

@anandvkulkarni.bsky.social
@juanpabloarab.bsky.social
@blaneymd.bsky.social
ebtapper.bsky.social
Steroids did not help people with alcohol-associated hepatitis in this nations cohort

doi.org/10.14309/ctg...

#liversky
anandvkulkarni.bsky.social
Absolutely sir. Patient selection is the key!
Reposted by Anand V Kulkarni
vinayjaha.bsky.social
Congrats to inspiring investigators @anandvkulkarni.bsky.social @juanpabloarab.bsky.social and team, for late breaking abstract about rapid taper of steroids in AAH at #TLM24
⤵️ infections, hospitalizations with rapid taper
💫 changing practice in management of AAH
#LiverSky #AASLD
anandvkulkarni.bsky.social
Hey Vinay, thank you. Nice meeting you.
Best
Reposted by Anand V Kulkarni
robbrierley.bsky.social
Dose tapering reduced incidence of infection and use of antibiotics. No difference noted in survival #TLM24 #LiverSky
Reposted by Anand V Kulkarni
robbrierley.bsky.social
Anand Kulkarni presents data from the STASH trial of dose tapering vs fixed dose corticosteroids in patients with severe alcohol-associated hepatitis #TLM24 #LiverSky
anandvkulkarni.bsky.social
No difference in mortality though.
Reposted by Anand V Kulkarni
ebtapper.bsky.social
This study by challenges dogma

@anandvkulkarni.bsky.social gave a tapering dose of prednisone for alcohol hepatitis instead of 40mg for 28 days

And it paid off with fewer infections

@tonybreu.bsky.social
anandvkulkarni.bsky.social
Drugs for Mash cirrhosis by Prof Mazen Noureddin #TLM24
anandvkulkarni.bsky.social
Join to learn and discuss about Management of ACLF #Aasld #liversky
Reposted by Anand V Kulkarni
robbrierley.bsky.social
I’ll be moderating a webinar tomorrow (Nov 13th) in conjunction with The Hepatitis Fund, as part of London Global Cancer Week 2024.

Join us to learn more on how liver cancer can be prevented via the elimination of viral hepatitis!

Register: us06web.zoom.us/webinar/regi...

#GastroSky #LiverSky